What is the Projected CAGR value of the Oncology Companion Diagnostics Market?
Oncology Companion Diagnostics Market is expected to grow at a CAGR of 12% during the forecasting period 2023-2030.
Who are the key players in Oncology Companion Diagnostics Market?
Key players are Agilent Technologies, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc., bioMérieux SA, Invivoscribe, Inc., Pillar Biosciences, Inc.
Which is the fastest-growing region in the Oncology Companion Diagnostics Market?
Asia Pacific is the fastest-growing region in the Oncology Companion Diagnostics Market.
Which is the Largest Market Share in the Oncology Companion Diagnostics Market?
North America is the Largest Market Share in Oncology Companion Diagnostics Market.